Adamas Pharmaceuticals, Inc.: cash_and_equivalents

Value{"amount": 40604000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"}
Period (as of 2018-06-30)
Statuscurrent
EntityAdamas Pharmaceuticals, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001628280-18-010334 · Open the official SEC filing →
Retrieved: 2026-08-19T12:42:17.795211+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001328143/cash-and-equivalents/2018-06-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/508271c9-c81b-4c9b-9e6a-5f1ec8fa53a1

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies